Abstract: A remote surveillance system (the system) of the present invention is designed to have a long independent operation, portability, and wireless transmission of digital data from any location worldwide. The system includes a hybrid power element having novel hydrogen storage and generation device, light weight polymer electrolyte membrane (PEM) fuel cell, and the low power and low weight electronics. The system also includes multiple day/night cameras, motion detector, global positioning system (GPS), and wireless module. The system is packed in a back pack case and is easily carried between multiple locations due to low weight and compacts size.

Abstract: This invention relates to compositions and methods for providing protection against, or reducing the severity of, toxic shock syndrome, septic shock, food poisoning, and autoimmune diseases which are associated with toxin producing bacteria. This invention also relates to methods of using peptides, derivatives, mimetics, and antibodies for the prevention and treatment of toxic shock syndrome, septic shock, food poisoning, and autoimmune diseases, and other related diseases, conditions, and syndromes.

Abstract: This invention provides a novel immunogenic composition and vaccine, processes for producing them and methods for immunization against infections and disease caused by group A Streptococci. The compositions include group A streptococcal polysaccharide covalently linked to protein or liposomes to form immunogenic conjugates. The method of immunization for this invention comprises administering to an individual an immunogenic amount of group A polysaccharide. The group A polysaccharide may be administered as a vaccine either on its own, conjugated to proteins or conjugated to liposomes. Additionally, the group A polysaccharides may be associated with an adjuvant. This invention is particularly useful for providing both active and passive immunogenic protection for those populations most at risk of contracting group A Streptococcal infections and disease namely adults, pregnant women and in particular infants and children.

Abstract: Purified glomerular proteoglycans are used as a basis for a diagnostic test for glomerulonephritis in humans involving an immunological reaction between the purified proteoglycans and patient area. A new method for purification of glomeruli proteoglycan antigens is described using guanidine extraction.

Abstract: Purified glomerular proteoglycans are used as a basis for a diagnostic test for glomerulonephritis in humans involving an immunological reaction between the purified proteoglycans and patient sera. A new method for purification of glomeruli proteoglycan antigens is described using guanidine extraction.